Africa Asean GLOBE-NEWSWIRE MENA Pakistan Press Releases South Africa

SELLAS Life Sciences Announces Positive Pivotal Phase 3 REGAL Trial Data Showing Immunotherapeutic Cancer Vaccine, Galinpepimut-S (GPS), Demonstrated a Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with Acute Myeloid Leukemia

– REGAL trial met its primary endpoint with GPS demonstrating statistically significant and clinically meaningful reduction in risk of death by 41% with median overall survival of 24.0 months versus 14.7 months for best available treatment, and a hazard ratio of 0.59 (p=0.035) – – Company plans to meet with the U.S. Food and Drug […]

General General News

Pharmaceutical Industry Urged to Rethink Business Models for Equitable Medicine Access

Seoul:The pharmaceutical industry is being called upon to revise its business models and partnerships to make medicines more affordable and accessible, especially in regions with the greatest need. Efforts over the past two decades have focused on con…

Africa Asean GLOBE-NEWSWIRE MENA Pakistan Press Releases South Africa

EAACI calls for allergy and respiratory health to be part of climate action at COP31

A dedicated symposium will connect scientific evidence, patient needs and climate policy, advancing EAACI’s vision of a future free from the burden of allergy and asthma. ZURICH, Switzerland, Nov. 16, 2026 (GLOBE NEWSWIRE) — The European Academy of Allergy and Clinical Immunology (EAACI) will bring allergy and respiratory health into the dialogue at COP31, advocating […]